Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT-Reference-Cited by-同舟云学术

Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT

Published:2014-04-07 Issue:7 Volume:49 Page:950-954
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Czerw T,Labopin M,Gorin N-C,Giebel S,Blaise D,Dumas P-Y,Foa R,Attal M,Schaap N,Michallet M,Bonmati C,Veelken H,Mohty M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201464.pdf

Reference29 articles.

1. Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L et al. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 2006; 24: 3187–3205.

2. Breems DA, Löwenberg B . Acute myeloid leukemia and the position of autologous stem cell transplantation. Semin Hematol 2007; 44: 259–266.

3. Seshadri T, Keating A . Is there a role for autotransplants in AML in first remission? Biol Blood Marrow Transplant 2009; 15: 17–20.

4. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47: 906–923.

5. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85–86.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Prophylactic Post-Chemotherapy G-CSF on the Relapse Rates in Patients with Acute Myeloid Leukemia: A Meta-Analysis;Cancer Investigation;2024-06-26

2. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis;Hematology;2018-03-08

3. Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation;Biology of Blood and Marrow Transplantation;2016-11

4. Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marr;Cancer;2016-03-28

5. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects;Bone Marrow Transplantation;2015-08-17